The approval of sintilimab for classical Hodgkin's lymphoma: views and perspectives of anti-PD-1/PD-L1 antibodies in China

Lignende værker

• Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma.
  af: Peter Hollander, et al.
  Udgivet: (2018-01-01)
• Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
  af: Hollander, Peter, et al.
  Udgivet: (2018)
• Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
  af: Wang, Yucai, et al.
  Udgivet: (2018)
• High proportions of PD-1(+) and PD-L1(+) leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome
  af: Hollander, Peter, et al.
  Udgivet: (2017)
• PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
  af: Roemer, Margaretha G.M., et al.
  Udgivet: (2016)